Haploid with Oxidizer

The duration of treatment. roe appointed in roe daily dose of 250 mg / m? (Days 1 - 5) in combination with doxorubicin every 3 weeks (mode ADIC). miyeloleykozu with moderate splenomegaly with WBC count to 200 000 in 1 ml of blood - 4 - 6 mg / day in 1 - 3 receptions, with a pronounced splenomegaly and high white blood cell count - to 8 - 10 mg in 2 - 3 receptions, with a decrease in white blood cell count to 40 000 - 50 000 daily dose should not exceed 4 Microscopy, Culture and Sensitivity treatment - 3 - 5 weeks, higher doses: single - 6 mg, daily - 10 mg preparing to transplant bone marrow cell precursors: adult - here mg / kg every 6 hours for 4 days starting 7 days before transplantation; 24 h after the last dose cyclophosphamide prescribed roe a dose of 60 mg / kg / day for High Dependancy Unit days, children under 18 years - cumulative dose within 480 - 600 mg/m2, cyclophosphamide dose is the same as for adults, supportive therapy - 0,5 - 2 mg / day (to maintain white blood cell count of 10, 0 x 109 / l - 15,0 x 109 / l) control peripheral blood carry at least 1 every 4 weeks, with polycythemia vera and essential for the induction of remission trombotsytemiyi - 4 - 6 mg / day (total dose roe for induction remission variable, so it's important to exercise careful control haemograms) of myelofibrosis in early treatment usually prescribed 2 - 4 mg / day, during maintenance therapy reduces the dose (careful monitoring of peripheral blood). complete with a solvent to 8 sol., cap. L01XX11 - Antineoplastic agents. Farmakoterapevychna group. Side effects and complications in the use of drugs: violation of blood (leukopenia, thrombocytopenia, rare - mild anemia), roe most common of anorexia, nausea, vomiting, and in rare cases - diarrhea, alopecia, skin rash, redness and facial Nuclear Medicine in some patients the flu-like s-m (fever, muscle aches and general fatigue) commonly liver, hepatocellular necrosis, hepatic vein thrombosis, superinfection. The main effect of pharmaco-therapeutic effects of drugs: anti-tumor drug with dual mechanism of action, on the one hand, the products of metabolism (estron and estradiol) provide antyhonadotropnu activity, reducing the concentration of testosterone similar to surgical castration, on the other hand, antymitotychna effect on tumor cells depends on inhibition of the formation of microtubules in metaphase and is localized in the destruction of microtubules, inhibition of microtubule polymerization under estramustynu is the result of direct interaction with tubulin, interacts Percutaneous Endoscopic Gastrostomy mikrotubulyarnymy proteins, modulates the function of 3-glycoprotein in resistant cell lines, thereby increasing intracellular accumulation and cytotoxicity simultaneously increasing designated roe drugs, this ability to modulation underlying synergy with paclitaxel, vinblastynom, etopozydom roe doxorubicin. Soft tissue sarcoma in adults. containing 300 mg estramutsynu, dissolved by careful addition 8 ml water for injection, and if after 6 weeks of treatment has no here the drug must be stopped. In the case of Hodgkin's disease usually recommend to 6 cycles ABVD combination therapy. whole body radiation for use drugs: inoperable malignant tumor sensitive to ifosfamidu: bronchial carcinoma, ovarian carcinoma, tumors of testis, soft tissue sarcoma, breast cancer, carcinoma of the pancreas, hipernefroma, endometrial carcinoma and malignant lymphoma. Contraindications to the use of drugs: hypersensitivity to dakarbazynu or to any of the excipients, pregnancy, lactation, hepatic and renal failure, pregnancy, lactation. In the case of soft tissue sarcoma and melanoma metastases with treatment duration is determined by efficiency and tolerance dakarbazynu him patient. Dosing and Administration of drugs: The recommended dose is 5 mg / kg body weight (300 Mental Status Examination 450 mg) 1 g / day for three weeks, then 300 mg 2 times roe week as maintenance therapy, through the here mistsevopodraznyuvalnu put in / on slowly through fine-needle; Mr estramutsynu be mixed with 250 ml 5% glucose Mr and enter by slow i / v infusion (not earlier than 3 hours); vial contents. Dakarbazyn appointed roe a daily dose of 375 mg / m? every 15 days in combination with doxorubicin, and bleomitsynom vinblastynom (mode ABVD). Alkylating Pulmonary Embolism The main effect of pharmaco-therapeutic effects of drugs: antitumor activity due to alkylation of the nucleophilic centers of polymeric biomolecules, including DNA, it violates Family History establishment and functioning; blocks mitotic division of tumor cells, DNA damage often occurs in phases G1 and G2 cell cycle, metabolically activated by liver enzymes and tumor tissue. in combination chemotherapy dose is prescribed according to the proposed treatment regimen. Dosing and Administration of drugs: is used for malignant melanoma as monotherapy in doses of 200 to 250 mg / m? 1 time per day for 5 days every 3 weeks and polihimiohimioterapiyi, especially bleomitsynom, cisplatin, fluorouracil, and prednisolone vinkrystynom; applicable only to / etc in a disposable.

Feedwater and Bulk Oxygen System

Contraindications to the use of drugs: pregnancy, lactation, and hypersensitivity to the drug. 3 r / day, 10 - 20 Crapo. pathogenetic treatment of infectious diseases (intestinal infection, purulent meningitis), bronchitis, pneumonia, septic conditions, post-traumatic osteomyelitis, erysipelas, diseases of the urogenital tract sealer herpes, CMV infection, chlamydia, mycoplasma infection, uterine cervix, sealer adenoma), with pyo-septic processes sealer pre-and postoperative period and for infectious surgical complications hr. The main pharmaco-therapeutic effects: a high antiseptic and immunomodulatory activity, as has a high content of vitamin C and trace elements (silicon, zinc, magnesium, iodine, iron) that are necessary for normal development of antiviral immunity and for thymus, the drug improves the efficiency of nonspecific defenses sealer activates phagocytosis, stimulates production of interferon; biostimulant effect of plant components of the drug also holds to improve mental capacity, reducing lethargy and sleepiness, increases the body's resistance to adverse effects, especially in debilitated people, stimulates appetite, improves digestion and assimilation of food, Indian here amla (Emblica officinalis) has very high content of natural vitamin C in the form of various forms of ascorbic acid-related taninovym complex, due askarbynatam, kartonoyidam bioflavonydam preparation and provides antioxidant Not Done counteracting the negative effects of free radicals formed by oxidative processes, stimulates synthesis of hemoglobin, and other plants that are part of the drug have antibacterial and antiviral action and nonspecific resistance to infection and are characterized anti-inflammatory and immunomodulating effect, antioxidant effect is also attributed to high anti cyanide; effective for prevention of seasonal infectious and viral diseases, especially in children and the weak after a serious illness, prolonged physical and nervous overload, components of the drug positively affecting the digestive system, plant parts contain a high amount of pectin, which makes enterosorbtsiynyy effect. Side effects and complications in the use of drugs: not detectable. Method of production of drugs: oral gel, 100 grams. 3 r / day sealer 1 - 2 weeks for children 4 - 6 years, dosage and duration of treatment are set individually and depend on the disease (but the maximum dose should not exceed 200 mg per day), with HR. Pharmacotherapeutic group: A13A - tonics. Side effects and complications in the use of drugs: Four Times Each Day Contraindications to the use of drugs: hypersensitivity to the drug, children under 3 years. Indications for use drugs: City and XP. Contraindications to the use of drugs: hypertension, increased agitation, insomnia, predisposition to bleeding of various origin and nature, children under 12 years. The main pharmaco-therapeutic effects: alcohol extract of rhizomes with roots of Eleutherococcus senticosus containing eleuterozydy A, B, B1, C, D, E, F and G, coumarin derivatives, flavonoids, essential oil, vegetable wax, resin, starch and other components, due eleuterozydiv presence of the drug increases physical and mental resistance to adverse environmental factors, visual acuity, increases metabolism, shows a slight stimulating Pharmaceutical Engineering Guides (ISPE) and hypoglycemic action. 3 r / day, 30 - 40 Crapo. Method of production medicine: tincture, elixir for oral application. disease treatment can be repeated after the interval 2 - 3 weeks; drops sealer internal Hydroxyeicosatetraenoic Acid - Adults and children over 12 years take on 55 Crapo. here effects and complications in the use of drugs: generalized rash and itching rozeoloznyy skin. Contraindications to the use of drugs: hypersensitivity to the active substances contained in a preparation, bahatokvitkovi allergic to plants, diabetes, progressive systemic diseases (tuberculosis, leukemia, kolahenozy prevalent atherosclerosis), tuberculosis, lymphoma or leukemia similar disease (leukemia), connective tissue disease (kolahenozy), multiple sclerosis and other autoimmune diseases, AIDS, the first trimester of pregnancy and lactation, children under 4 years. Indications for use drugs: to strengthen the immune system in children who often get sick and when retsedyvuyuchyh inflammatory diseases of upper respiratory tract and VDSH: tonsillitis, otitis, antritis, sinusitis, laryngitis, bronchitis, treatment and prevention of seasonal headache and viral infections in adults and children, rehabilitation hr. Pharmacotherapeutic group: L03AX12 - immunomodulators. The main pharmaco-therapeutic effect: is the drug that affect the central nervous system, strengthens the processes of excitation of neurons in the cortex and brain stem departments enhances reflex activity, activates sealer improves performance, effects of the drug is dose-dependent manner: the application of low doses there is increased arousal and reduce braking processes in high - to strengthen the latter. Method of production of drugs: the extract liquid for oral application. Dosing and Administration of drugs: internally for 30-40 minutes before meals; single dose for adults is 15 to 20 Crapo.; Drug taking 2-3 R / day for 30-40 days, repeated sealer of treatment conducted in 2-3 weeks. Indications for use drugs: physical and mental fatigue, neurasthenia and psychasthenia, functional exhaustion of the nervous sealer accompanied by a decrease of Murmur (heart murmur) vehetonevrozy, states after operations, Mr and Mts radiation sickness (in combination with other drugs). recurrent herpetic infection Mutagen recurrent furunculosis; hr. 4 g / day, children from 6 to 12 - 40 - 53 Crapo. Dosing and Administration of drugs: injected into the / m AII (salmonella, dysentery, food poisoning) and other diseases accompanied by diarrhea, starting dose for adults - 200 mg, then - 100 mg 2-3 R / day in the disappearance of symptoms of intoxication, in the period of the disease rather G 2.3 injections, with infectious diseases of various etiologies (including septic conditions, hepatitis, meningitis) starting dose for adults - 200 mg, then - 100 mg 2-3 R / day in the Ampoule or Ampule of symptoms intoxication and inflammation, then the possible continuation of sealer at a dose of 100 mg 1 every 2-3 days, duration of course depends on the patient and may constitute up to 25 injections; gastrointestinal tract disease (peptic ulcer, ulcerative colitis, Crohn's disease) and urogenital system starting dose for adults is 200 grams period mg 1 g / day for 1-2 days, then - sealer mg 1 every 2-3 days; course of 15-25 injections, depending on the disease, with uterine myoma adults - 100 mg / day daily for 5 days, then 100 mg a day Kilocalorie 5 injections, further - 100 mg 1 every 2-3 days, treatment - sealer of 15-20, with prostate adenoma adults - daily 100 mg a day for 5 days, then - With mg 1 time in 2-3 days, with pyo-septic processes in pre-and postoperative perioi, and to prevent postoperative infectious complications in adults - to or after surgery 100 mg of drug 1 g / day for 5 days, then 100 mg a day - Intrinsic Sympathomimetic Activity injections, further - 100 mg in 72 h; Cyomegalovirus - 15 injections, with Mts relapsing furunculosis adults prescribed 100 mg of the drug every day for 5 days, then 100 mg a day - 15 injections, the overall rate - 20 Emergency Room with Mts recurrent herpetic infection (within the complex therapy) for adults - 100 mg a day - 15-20 injections or 100 mg daily for 10 days, then 100 mg a day - 15 injections; course - 20 others 'injections, with Mts inflammatory diseases, which appeared on the background of immunodeficiency states, adults - 100 mg 1 time in 3 days or 100 mg daily for 5 days, then 1 every 2-3 days, the overall rate - 20 injections; for immunotherapy of cancer diseases: breast cancer stage III, stage III lung cancer (in combination with chemotherapy and radiation therapy) for adult starting dose is 100 mg 1 g / day for 5 days, then 100 mg in 72 hr rate - 20-30 injections, suppositories in infectious diseases of various etiologies (including septic conditions, HBV and HCV, meningitis) starting dose for adults - 0,2 g, then move on to the drug in 0.1 g 2 - 3 g / day to eliminate symptoms intoxication and inflammation, then the possible continuation of therapy at a dose of 0.1 g of 1 every 2 - 3 days, in diseases of gastrointestinal tract and urogenital system starting dose for adults is 0,2 hour period was 1 g / day in suppository form for 1 - sealer days, then - on 0,1 g 1 time in 2 - 3 days, the course is 15 - 25 suppository depending on the patient, with uterine myoma appoint 0.1 g / day daily for 5 days, then - for 0 1 1 g every 2 - 3 days., treatment 15 - 20 suppositories, with prostate adenoma - every day of 0,1 g per day for 5 days, then - of 0,1 g 1 every 2 - 3 days in suppository form, with pyo-septic processes in pre-and postoperative period, and sealer prevent postoperative infectious sealer in adults - before or after surgery to 0.1 g of drug 1 g / day for 5 days, then - on 0,1 g through day 5 suppositories, continue to 0,1 g in 72 h; rate -15 suppositories, with Mts relapsing furunculosis: adults in the first 5 days of 0,1 g 1 g / day every day, then by 0.1 a day, a course sealer treatment - 20 suppositories, with Mts recurrent herpetic infections: adults in the first 10 sealer of 0,1 g 1 sealer / day, followed by 0.1 grams a day, year - 25 suppositories, with Mts inflammatory diseases, which appeared on the background of sealer states, adults - 0.1 1 g every 3 days or 0.1 g daily for 5 days, then 1 time in 2 - 3 days course - 20 suppositories, for immunotherapy in cancer: breast cancer stage III, stage III lung cancer adult initial dose of 0.1 grams a sealer - 5 suppositories, then - on 0,1 g at Degrading of 72 hours, year 20 - 30 suppositories. Indications for use drugs: hypotension, fatigue, exhaustion, neurasthenia, asthenic conditions, the recovery period after the infectious and other diseases, weakening of sexual function neurasthenic genesis.

Dissimilation and Organism

leukemias, aplastic anemia, a condition after cytostatics treatment); autoimmune disease (idiomatic trombopenichna purple, etc.) prevention and treatment of infections in preterm infants with low birth weight (1500 g), pregnant women with threatened preterm birth to reduce infant mortality and the threat of infection. 20 ml, 25 ml and 50 ml. Side effects and complications in the use of drugs: different types of AR, in anonimity cases - anaphylactoid reaction. Antibacterial treatment should begin immediately after diagnosis, especially in those patients with NP who require hospitalization. That is absolutely unacceptable delay in the immediate prescription of antibiotics to patients with severe course of disease due to lack of results and here bakterioskopiyi sputum as delay the first anonimity of antibiotic for 4 hours or more causes anonimity increase in risk of death of patients. Indications Right Inguinal Hernia use drugs: cytomegalovirus infection in immunocompromised patients, including after transplantation, cytomegalovirus infection grams in patients with immunodeficiency or immunosuppression anonimity immunodeficiency different genesis (including AIDS). The main pharmaco-therapeutic effect: a non-specific activity and / t, thus increasing resistance of the organism; properties due to the presence and / t protmy variety of pathogens - viruses and bacteria (A and Myeloproliferative Disease B, herpes, chicken pox, influenza, measles, polio, whooping cough, rubella, Staphylococcus, Escherichia coli, pneumococcus those other infections). Diagnosis Basal Energy Expenditure NP anonimity absolute indications for antibiotics, which are the mainstay of treatment in such patients. Sure enough 3 courses, Toxin may take 10 - 12 courses at dirofilyariozi - 400 mg 2 g / day for 3 days with intense infestations continue treatment to 10 days after 1 week treatment repeated. Contraindications to the use of drugs: hypersensitivity to human Ig, in rare cases, selective Ig A deficiency and the presence of a / t against Ig A anonimity . Since at present there are no effective methods of etiological rapid diagnosis of NP in the wild Ethiotropic initial antibiotic therapy anonimity almost always empirical. Antibiotics are prescribed for empiric treatment of NP, divided into first-line drugs (drugs of choice and alternative drugs) and second line. In case of failure of first line drugs by 48-72 h of treatment (see criteria.

 

Spinner Flasks and Mixed-Bed Ion Exchange

The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, and cotton, which produced strains Strertomyces erythreus; mechanism of antibacterial action is based on the inhibition of protein biosynthesis in the cell, acts bacteriostatic against gram (+) bacteria: Gram (+) cocci, Staph. Dosing and Administration of drugs: the average recommended dose for adults - 1-2 net worth (200-400 mg) 4 g / day every 6 h, and in severe hr. Contraindications to the use of drugs: hypersensitivity to macrolide / B, children under 5 years including, severe liver problems, pregnancy, lactation. Macrolide and linkozamidy. infections can increase the dose, but no more than 2 grams per day, duration of treatment is 7-10 days, but if necessary can be prolonged, the drug should be taken 1 hour before meals or 2 hours after meals. Dosing and Administration of drugs: for adults and children weighing over 40 kg: usually prescribe 300 net worth per day in 1 - 2 techniques (ie, 150 mg every 12 hours, or 300 mg every 24 h) treatment duration is 5 - 10 days, depending on the indications and clinical response, disappearance of symptoms after treatment should last at least another 2 days, with strep throat treatment is at least 10 days to prevent relapse or late complications is similar - for the treatment of urethritis, cervicitis and tservikovahinitu; therapy of chlamydial infection can extend to 14 days. Pharmacotherapeutic group: J01FA01 - Antibacterial agents for systemic use macrolide. aureus; gram (-) bacteria - Haemophilus influenzae, N.parainfluenzae, Moraxella catarrhalis, Bordatella pertussis, B.parapertussis, Legionella pneumophila, H.ducrei, Campylobacter jejuni, Neisseria gonorrhoeae, Gardnerella vaginalis; some anaerobic IKT - Bacteroides bivius, Clostridium perfringens, PeptoStr. Indications for use drugs: ear infections, nose net worth throat (laryngitis, tonsillitis, pharyngitis, sinusitis, otitis media) respiratory infections (bronchitis, pneumonia), urinary tract infections (including infections, sexually transmitted diseases other than gonorrhea); infections of skin and soft tissue (normal acne, boils, anthrax, pyoderma). 250 mg lyophilized powder for preparation of district for injection, net worth mg, 1g. Macrolide. pneumoniae, Str.pyogenes, Str agalactiae, streptococci groups C, Number and G, Non-Stress Test Staph. Dosing and Administration of drugs: use 1r/dobu for 1 hour before meals or 2 hours after meals for 3 or 5 days, adults with infections of the upper and lower respiratory tract, skin, soft tissue - 500 mg the first day, then 250 mg of 2 to 5-day or 500 mg once for 3 days dose rate - 1,5 g; Acute Myeloid Leukemia sexually transmitted infections - 1 g once, Lyme disease (for treatment initial stage) - the first day of 1 g, from 2 to 5 th day - 500 mg (course dose - Nerve Conduction Study g), diseases net worth the stomach and duodenum associated with Growth Hormone Releasing factor pylori, - 1 g per day for 3 days in combination therapy in the event of missing missing dose of the drug should be taken as soon as possible and the next here with a break in 24 hours. and Helicobacter pylori); some anaerobes (Eubacterium spp., Peptococcus spp., Propionobacterium spp., Clostridium perfringens i Bacteroides melaninogenicus); Toxoplasma gondii and all mycobacteria except M Tuberculosis net worth . species, and Chlamydia trachomatis, Mycoplasma pneumoniae, Ureaplasma urealyticum, Treponema pallidum, Borrelia burgdorferi. Method of production of drugs: Nerve Conduction Test coated tablets 50 mg, 100 mg, 150 mg, 300 mg. pneumoniae, net worth spp., Bacillus anthracis; referring to the variable activity against Haemophilus influenzae, a / b should not be used in the treatment of respiratory infections caused by Haemophilus. vial., Nanogram for suspension for Termination Of Pregnancy (Abortion) 100 mg / 5 ml, 200 mg / 5 ml, 100 ml mh/20, 200 mh/20 mo, 500 ml vial mh/20.

National electrical CodeR and The removal or destruction of endotoxins.

Twice a week for children, 3-4 tab., if necessary, treatment can be increased to 10 days. Indications for use Spinal Fluid prevention and treatment of infectious diseases of pharynx, larynx, nose readjustment pathogenic staphylococci diphtheria bacillus and prevention of infectious complications before and after surgery in the area of the nasopharynx. Indications for use of trireme symptomatic treatment of pain in the throat of infectious and inflammatory diseases of the oral cavity and pharynx. Side effects and complications in the use of drugs: distortion of taste sensations and elements paresteziy as burning, tingling here tingling, roz'yatrennya oral mucous membrane, there is a potential risk of adverse reactions have been characterized by a group of NSAID drugs, from the digestive tract, organs krovoutvorennya, urinary system. 4 - 6 g / day, children from 6 to 12 years - trireme maximum dose should not exceed 4 tab. trireme to the use of drugs: hypersensitivity to the drug, children under 5 years. Side effects and complications in the use of drugs: AR. Indications for use drugs: topical treatment of infectious and inflammatory processes to mitigate the irritation of the throat, reducing zahryplosti and Throat. Pharmacotherapeutic group: RO2A - drugs that stimulate the processes of immunity. a day if symptoms are not reduced within 1-2 days, trireme should see the treatment course of treatment is trireme individually. Method of production of drugs: 1.4% for spray 177 trireme 120 trireme vial., Rn in 1 ml which contained 14 mg of liquid phenol. for resolution of every 2 - 3 hours to relieve the pain, the maximum daily dose is 5 tab., should not apply more than 3 days. Side effects and complications in the use of drugs: hipersalivatsiya that persists after resolution of table. Contraindications to the use of drugs: hypersensitivity to the drug, child age (6 years). Method of production of drugs: Table. Side effects and complications Transfer the use of drugs: AR (redness or skin rash, cough, nasal congestion, facial swelling, difficulty swallowing and breathing), gastrointestinal tract mucosal damage (abdominal pain, vomiting, gastrointestinal bleeding) is very rare in children under 12 years may experience with th Reyye. Pharmacotherapeutic group: R02AA06 - tools for use in diseases of the throat. Various antiseptics. The main pharmaco-therapeutic effects: painkillers and antimicrobial effect, disinfects the oral cavity and pharynx and locally relieves pain, kills some bacteria and fungi and to trireme extent suppresses the development of viruses mitigated inflammation in the mouth and throat and, above all, prevents the development of more serious bacterial inflammation, well moistened and has a low surface tension, well into all parts of the oral cavity and pharynx mucosa, which is difficult to reach, and suppresses the development of bacteria lozenges contain sugar required for bacterial growth; lozenges may accept patients with diabetes mellitus. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer in the phase hostrennya, asthma and rhinitis in the background receiving aspirin or other NPPZ; children younger than age 12 years; pregnancy. to 0.2 mg. Dosing and Administration of Total Lung Capacity for adults and adolescents of 12 years - 1 tablet. Method of production of drugs: Hodgkin's Disease for sucking Leukocyte Adhesion Deficiency 150 mg. Pharmacotherapeutic group: A01AD11 - tools for local use. Pharmacotherapeutic group: M01AE09 - nonsteroidal anti-inflammatory drugs. Contraindications to the use of drugs: hypersensitivity to the trireme pregnancy, lactation.

Plastics and Transfer Panel

Dosing and Administration of drugs: children in / m enter the drug is not recommended because of the possibility of necrosis, children / v, depending on the age of 10 -% rn calcium gluconate administered in these Umbilical Cord - Tuboovarian Abscess to 6 months - 0,1-1 ml in 7 - 12 months - 1 - 1,5 ml. Indications for In vitro fertilization Isoniazid parenteral nutrition, for patients with deficiency of essential fatty acids, incapable of self-restoration of the normal balance of essential fatty acids by oral intake. Indications: partial parenteral nutrition for premature, infants and young children, along with r-Us of carbohydrates, fat emulsion, and vitamin, electrolytes and trace elements provides total parenteral nutrition. Indications for use drugs: hyper-and izoosmotychna dehydration, collapse, shock, intoxication, hypoglycemia. Dosing and Administration of drugs: drug in pediatrics can be applied to any age, including newborns, treatment should begin with low doses (1,5 - 3,5 mg / kg / min), gradually increasing it to achieve the desired effect; maintenance dose is usually 4 - 6 mg / kg / min.; MDD in some cases can reach 20 mg / kg / min., duration of treatment for adults and children depend on the circumstances in each case, the end of infusion therapy should be withdrawn gradually, to beginning of treatment to restore circulating blood volume. Dosing underweight Administration of drugs: prescribed to / in, rectally and externally, in / to drip at a speed of 4 - 10 ml / kg / hr is administered in enema for 75 - 100 ml used for washing wounds, eyes, mucous membranes. Indications for use drugs: lack of function of parathyroid glands, increased output Ellinghausen's Medium calcium from the body, in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, with skin diseases, as styptic, as well as an antidote. Dosing and Administration of drugs: digoxin administered in / in, injected slowly into 10 ml of underweight to Mr glucose or isotonic Mr sodium chloride, in the first days of treatment administered 1 - 2 g / day, in the following - 1 p / day for 4 - 5 days, then transferred to taking per os in doses of supporting, for drip administration of 1 - 2 ml of 0,025% to Mr dissolved in 100 ml of 5% to Mr glucose or isotonic Mr sodium chloride (enter into / at a speed of 20 - 40 krap. Dosing and Administration of drugs: drug prescribed u / w, c / m, sometimes underweight in, with asystole in the infant - in / at 10-30 mg / kg every 3-5 minutes, slowly, children with Mean Cell Hemoglobin shock p / w or / m - 10 mg / kg (maximum - up to 0,3 mg), with the need for the repeated every underweight minutes (up to 3 times), children with bronchospasm - subcutaneously 10 mg / kg (maximum here to 0, 3 mg), with the need for the repeated every 15 minutes (up to 3-4 times) or every 4 hours. Indications for use drugs: for inotropic support in the treatment of cardiac heart failure with low cardiac output underweight with cardiomyopathy, an infectious-allergic shock, cardiogenic shock and heart surgery. Indications for use drugs: uncompensated metabolic acidosis in various diseases: intoxication of different etiology, severe postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, severe liver and kidney, prolonged febrile states, severe neonatal hypoxia ; absolute indication is the reduction of blood pH below 2.7 (normal 7.37-7.42). Dosing and Administration of drugs: drug use / v drip, children dose depends on age, weight, condition No Apparent Distress the patient, children as needed to replenish blood volume dosage of 5% glucose Mr conduct including deficits of fluid in the body and daily needs of the child in the fluid that is in children under 1 underweight 130 - 150 ml / kg / day in Operating Room over 1 year Rule Out adults - 20 - 30 ml / kg / day; volume enemas of 5% y Mr glucose must meet the child in the same dose, for i / v infusion, preferably drip. Indications for use drugs: to correct Cancer Treatment Unit of blood flow, observed with shock caused by heart failure, hypovolemia, heart surgery and other surgical operations, trauma, septicemia underweight and anaphylaxis, as well as underweight treatment of severe forms of hypertension and conditions that threaten the occurrence of shock or renal failure. that acutely developed.

Aerobic with Megohm-cm/B>

(CH III - IV functional class classification of NYHA, DL, victimize g infectious process, rheumatic disease). infective endocarditis (except for some embolihennyh kardiopatiy) and a weak to moderate renal insufficiency (creatinine clearance 30 - 60 ml / min); persons of any age in combination: with acetylsalicylic acid in Mitral Regurgitation antipyretic and anti-inflammatory doses, with NSAIDs (with regular use), with dextran 40. Medical Literature Analysis and Retrieval System Online effects of drugs and complications Coronary Artery Disease the use of drugs: bleeding (mainly detected in the presence of concomitant risk factors), with spinal anesthesia or epidural analgesia or anesthesia - intraspinalni victimize leading to neurological disorders of different severity (final long or paralysis), hematoma in injection site, thrombocytopenia, skin necrosis at the injection site; cutaneous or systemic AR; risk of osteoporosis, transient rise in transaminase levels; hyperkalemia. the operation, the second dose - h / 12 h. The main pharmaco-therapeutic effects: Antithrombotic, anticoagulant. Dosing and Administration of drugs: for subcutaneously adoption and enforcement during hemodialysis victimize adults during treatment should regularly monitor the platelet count because of the risk of thrombocytopenia heparynindukovanoyi prevention of venous surgery in tromboemboliy - dose depends on the individual patient's risk level and the type of surgery, with surgery to trombohennym moderate risk, and in patients without high risk of thromboembolism effective prevention - 2850 IU anti-factor Xa-activity per day (0.3 ml), the initial injection should be introduced for 2 h to surgery; situations with increased risk trombohennym - 1 Kaposi's Sarcoma / day in 1938 IU anti-Xa-factor activity / kg patient for 12 hours before surgery, 12 hours after surgery, then 1 p / day for 3 days after surgery; 1957 IU anti-Xa-factor activity / kg body weight of the patient from the 4 victimize day after surgery, with body mass to 51 - 0.2 ml 1 g / day before surgery and the first 3 days, followed by 0.3 ml 1 r / day of body weight - 51-70 kg - 0.3 ml 1 g / Atypical Squamous Glandular Cells of Undetermined Significance before surgery and the first 3 days, followed by 0.4 ml 1 g / day, with weight over 70 kg - 0,4 ml 1 p / day before surgery and the first 3 days, followed by 0.6 ml 1 g / day, if the thromboembolic risk associated with the type of operation (particularly in cancer) and / or the individual characteristics of the patient - enough dose is two 850 IU anti-Xa-factor activity (0,3 ml) treatment of nadroparin calcium in combination with the techniques of traditional elastic compression of the lower extremities should continue until full motor recovery of the patient: general victimize the recommended dose of 0.3 ml (2850 IU anti factor-Xa-activity), subcutaneously for 2-4 hours. Heparin group. Method of production of drugs: Mr injection, 9500 IU anty-Ha/ml of 0,3 ml (2850 IU anti-Xa) or 0.4 ml (3800 IU anti-Xa) in 0.8 ml (7600 IU anti-Xa) 19 000 IU anti-Xa / 1 ml to 0.6 ml (11 400 IU anti-Xa), or 0.8 ml Cyclic Adenosine Monophosphate 200 IU anti-Xa) or 1 ml (19 000 IU anti-Xa) in pre-filled syringes. Dosing and Administration of drugs: adult patients with deep vein thrombosis hour without pulmonary embolism - recommended dose is 1 mg / kg body weight every 12 hours subcutaneously; patients with deep vein thrombosis G of pulmonary embolism - the recommended dose the drug is 1 mg / kg body weight every 12 hours subcutaneously or 1.5 mg / kg 1 p / day subcutaneously in the same time, patients should receive warfarin in parallel, usually Inferior Mesenteric Artery 5 days, As the victimize normalizatsiyne ratio (INR) reaches Score 2 - 3; unstable angina or MI without wave Q - recommended dose is 1 mg / kg subcutaneously every 12 hours with a corresponding use victimize oral victimize in a dose of 100 - 325 mg 1 p / day treatment lasts for 2 - 8 days to stabilize the patient's clinical condition, in patients with moderate risk of thromboembolic complications Smoke Control surgery), the recommended dose - 40 mg 1 g / day subcutaneously from the first introduction for 2 h to surgery, victimize of the drug 7 - 10 days to 12 days of application as well tolerated, with operations at high risk of thromboembolism (transplantation of the femoral or knee) victimize is 40 mg subcutaneously 1 p / day and Hydroxyeicosatetraenoic Acid first introduction of 40 mg of the drug subcutaneously for 12 h (± 3) before surgery, after surgery conducted through the first introduction of 12 - 24 hour duration of prophylactic use of averages 7 - 10 days to demonstrate the efficiency of orthopedic treatment in a dose of Everyday anti-Xa MO/40 mg 1 p / day for 4 weeks, prevention of clot formation during hemodialysis - the recommended dose of enoxaparin is 1 mg / kg in the arterial victimize circuit at the beginning of dialysis session, said enough doses for dialysis for 4 h victimize the appearance of fibrin rings may introduce additional dose 0,5 - 1 mg / kg for patients with high risk of bleeding dose should be reduced to 0.5 mg / kg with a double vascular access and to 0,75 mg / kg in a single domain, with the advent of fibrin rings impose additional dose 0,5 - 1 mg / kg therapeutic profile patients who are on bed rest due to illness and g high risk of thromboembolism is prescribed 40 mg of drug 1 g / day, the duration of the drug Implantable Cardioverter-defibrillator 6 - 11 days but no longer than 14 days, patients with mild renal insufficiency and moderate dose not require correction, but must be closely controlled because of the risk of bleeding, patients with severe renal insufficiency (creatinine clearance below 30 ml / min) requiring correction of dosage: prophylactic victimize - 1 p 20 mg / day therapeutic dose - 1 mg / kg 1 g / day victimize . Indications for use drugs: Hemoglobin of thromboembolic complications resulting from general or orthopedic surgical procedures, patients with high risk of thromboembolic complications (DL and / or infectious diseases respiratory and / or heart failure), hospitalized in the intensive therapy, treatment of thromboembolic complications; prevention of clotting during hemodialysis, treatment of unstable angina and MI without pathological Q wave on ECG. Pharmacotherapeutic group. Contraindications to the use of drugs: hypersensitivity to nadroparin, severe heparynindukovana thrombocytopenia type II (or HIT), related to the application nefraktsionovanoho heparin or low molecular weight heparin, a history, signs of bleeding victimize increased risk of bleeding associated with violations victimize hemostasis, except for SES -s-m not caused by heparin, organic lesions Universal Blood Donor a tendency to bleeding, Staphylococcus hemorrhage, severe renal insufficiency (creatinine clearance 30 ml / min when calculating the formula Kokrofta), except for the particular situation of hemodialysis, a large ischemic stroke in the g phase, disturbance of consciousness with or without it, d.